Karyopharm Therapeutics Inc. - KPTI

Insiders (Form 4) · last 180 days · showing up to 200 transactions · Form 144 is shown in the SEC filings tab · Updating…
Visible: 0
Transaction codes: P = Open-market purchase · S = Open-market sale · A = Grant/award · M = Exercise/conversion of derivative · G = Gift · F = Tax withholding · J = Other · A/D: A = Acquired (buy/receive) · D = Disposed (sell/give)
Filed Owner Title Code A/D Shares Price Value Shares after SEC
Mar 03, 2026 President and CEO S D 12,361.0 9.4095 116,310.83 267,030.0 View
Mar 03, 2026 EVP & Chief Medical Officer S D 5,066.0 9.4095 47,668.53 56,739.0 View
Mar 03, 2026 EVP & Chief Commercial Officer S D 4,604.0 9.4095 43,321.34 107,317.0 View
Mar 03, 2026 EVP, CLO&Secretary S D 3,526.0 9.4095 33,177.9 93,964.0 View
Mar 03, 2026 Chief Accounting Officer S D 559.0 9.4095 5,259.91 22,063.0 View
Mar 03, 2026 EVP, Chief Development Officer S D 5,101.0 9.4095 47,997.86 94,328.0 View
Feb 19, 2026 EVP, Chief Development Officer S D 378.0 8.63 3,262.14 99,429.0 View
Feb 09, 2026 President and CEO A A 81,060.0 0.0 0.0 279,391.0 View
Feb 04, 2026 EVP, CFO & Treasurer S D 1,626.0 6.3 10,243.8 85,105.0 View
Feb 03, 2026 EVP, CLO&Secretary A A 32,415.0 0.0 0.0 97,490.0 View
Feb 03, 2026 EVP, CFO & Treasurer A A 32,415.0 0.0 0.0 86,731.0 View
Feb 03, 2026 EVP & Chief Medical Officer A A 32,415.0 0.0 0.0 61,805.0 View
Feb 03, 2026 EVP & Chief Commercial Officer A A 32,415.0 0.0 0.0 111,921.0 View
Feb 03, 2026 EVP, Chief Development Officer A A 32,415.0 0.0 0.0 99,807.0 View
Jan 29, 2026 Chief Accounting Officer S D 50.0 7.03 351.5 22,622.0 View
Jan 29, 2026 Chief Accounting Officer A A 92.0 0.0 0.0 22,672.0 View
Jan 22, 2026 Chief Accounting Officer S D 265.0 5.96 1,579.4 22,580.0 View